Market Size of Global Swab and Viral Transport Medium Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 759.78 Million |
Market Size (2029) | USD 914.21 Million |
CAGR (2024 - 2029) | 3.77 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Swab & Viral Transport Medium Market Analysis
The Global Swab and Viral Transport Medium Market size is estimated at USD 759.78 million in 2024, and is expected to reach USD 914.21 million by 2029, growing at a CAGR of 3.77% during the forecast period (2024-2029).
The COVID-19 outbreak is expected to have a significant impact on the swab and viral transport tedium market due to the increasing demand for the diagnosis of the infections among patients .The swab and viral transport medium is expected to grow due to the intensified experiments for the COVID-19 in the research organizations and labs for developing vaccinations. The increasing research and development activities to produce COVID-19 vaccination are expected to propel the growth of the market during the pandemic period.
The increasing cases of COVID-19 among people across the globe are expected to propel the growth of the market. Owing to the need for developing vaccination and early diagnosis to treat the infection is expected to boost the growth of the market. According to World Health Organization (WHO), there were approximately 404 million COVID-19 cases recorded in the world till February 2022. Additionally, the report states that 5.7 million deaths were recorded across the world in 2022. The COVID-19 pandemic has led to an unexpected negative impact on the growth of almost all industrial sectors due to the sudden imposition of lockdown. Several economies across the world faced unprecedented losses due to the lack of labor and disruptions in the supply chains. The need for diagnosis of this COVID-19 infection in order to control the disease rate for the economies to rise again led to the demand for the swab and viral transport medium across the world. This increase in the incidence of many other infectious diseases across the globe led to the increase in demand for swabs and transport mediums resulting in the growth of the market. Moreover, a Surge in the number of new viruses emerging that can cause various diseases in humans is an additional factor contributing to the growth of the swab and Viral transport medium market. According to the article published in Nature, in 2021, Now, as pandemic restrictions ease, some respiratory viruses are returning in unexpected ways. Infections with Respiratory Syncytial Virus (RSV) started to rise in April 2021, which is also responsible for 5% of deaths in children under 5 years worldwide. Hence the increasing incidence of other infectious diseases is expected to drive the growth of the swab and viral transport medium market owing to the rising demand for specimen collection kits and diagnoses.
Swab & Viral Transport Medium Industry Segmentation
As per the scope of this report, Swab and Viral Transport Medium is a transport and collection system used for collecting clinical specimens for the diagnosis purpose. The Swab and Viral Transport Medium market is segmented by Type (Swab type (Nasopharyngeal swabs, Throat swabs), Transport medium), Application (COVID-19, Influenza, Herpes simplex Virus, ), End-user (Hospitals and clinics, Diagnostic Laboratories and Others) and Geography ( North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in (in USD million) for the above segments.
By Type | ||||
| ||||
Transport Medium |
By Application | |
COVID-19 | |
Influenza | |
Herpes Simplex Virus | |
Others |
By End User | |
Hospitals and Clinics | |
Diagnostic Laboratories | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Swab and Viral Transport Medium Market Size Summary
The swab and viral transport medium market is poised for steady growth over the forecast period, driven by the heightened demand for diagnostic tools and specimen collection due to the COVID-19 pandemic. The outbreak significantly increased the need for swabs and transport media, as they are crucial for diagnosing infections and developing vaccines. This surge in demand was further fueled by the rise in COVID-19 cases globally, prompting extensive research and development activities in laboratories and research organizations. The market's expansion is also attributed to the increasing incidence of other infectious diseases and the emergence of new viruses, which necessitate the use of swabs and transport media for effective diagnosis and treatment.
In the United States, the market's growth is supported by the high prevalence of infectious diseases and substantial healthcare expenditure. The region benefits from significant funding from public and private sectors, enhancing the production and development of diagnostic tools. The presence of major market players and advanced healthcare infrastructure further bolsters the market. The transport media segment is expected to dominate due to its critical role in specimen preservation and transport. Regulatory approvals and increased production capacities by key players have also contributed to the market's competitive landscape, with companies like Thermo Fisher Scientific and Becton, Dickinson and Company leading the charge.
Global Swab and Viral Transport Medium Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising cases of SARS COVID-19 across the world
-
1.2.2 Increasing Government initiatives to prevent infectious diseases
-
-
1.3 Market Restraints
-
1.3.1 Increasing number of false results
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Type
-
2.1.1 Swab type
-
2.1.1.1 Nasopharyngeal Swabs
-
2.1.1.2 Throat Swabs
-
-
2.1.2 Transport Medium
-
-
2.2 By Application
-
2.2.1 COVID-19
-
2.2.2 Influenza
-
2.2.3 Herpes Simplex Virus
-
2.2.4 Others
-
-
2.3 By End User
-
2.3.1 Hospitals and Clinics
-
2.3.2 Diagnostic Laboratories
-
2.3.3 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Swab and Viral Transport Medium Market Size FAQs
How big is the Global Swab and Viral Transport Medium Market?
The Global Swab and Viral Transport Medium Market size is expected to reach USD 759.78 million in 2024 and grow at a CAGR of 3.77% to reach USD 914.21 million by 2029.
What is the current Global Swab and Viral Transport Medium Market size?
In 2024, the Global Swab and Viral Transport Medium Market size is expected to reach USD 759.78 million.